Funiculosin: an antibiotic with antimycin-like inhibitory properties.
The antibiotic funiculosin mimics the action of antimycin in several ways. It inhibits the oxidation of NADH and succinate, but not TMPD+ascorbate. The titer for maximal inhibition in Mg2+-ATP particles (0.4-0.6 nmol/mg protein) is close to the concentrations of cytochromes b and cc1. Funiculosin also induces the oxidation of cytochromes cc1 and an extra reduction of cytochrome b in the aerobic steady state, and it inhibits duroquinol-cytochrome c reductase activity in isolated Complex III. The location of the funiculosin binding site is clearly similar to that of antimycin. In addition, funiculosin, like antimycin, prevents electron transport from duroquinol to cytochrome b in isolated Complex III if the complex is pre-reduced with ascorbate. Funiculosin and antimycin differ, however, in the manner in which they modulate the reduction of cytochrome b by ascorbate+TMPD.
D000332:Aerobiosis; D000818:Animals; D000880:Anthraquinones / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D002417:Cattle; D003580:Cytochromes / Q000378:metabolism; D003575:Cytochromes c1 / Q000378:metabolism; D004227:Dithionite / Q000494:pharmacology; D007700:Kinetics; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism*; D009206:Myocardium; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D010084:Oxidation-Reduction; D013053:Spectrophotometry; D013385:Succinate Dehydrogenase / Q000378:metabolism
D000880:Anthraquinones; D000935:Antifungal Agents; D003580:Cytochromes; D004227:Dithionite; D003575:Cytochromes c1; D013385:Succinate Dehydrogenase; D009247:NADH, NADPH Oxidoreductases